Patient-Reported Outcomes and Fibromyalgia

被引：18

作者：

Williams, David A. ^{[1
,2
,3
,4
]}

Kratz, Anna L. ^{[5
]}

机构：

[1] Univ Michigan, Univ Michigan Hlth Syst, Dept Anesthesiol, 24 Frank Lloyd Wright Dr,POB 385,Lobby M, Ann Arbor, MI 48106 USA

[2] Univ Michigan, Dept Internal Med, Taubman Ctr 3110, SPC 5368,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA

[3] Univ Michigan, Dept Psychiat, F6327 UH South,SPC 5295,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA

[4] Univ Michigan, Dept Psychol, F6327 UH South,SPC 5295,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA

[5] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2016年 / 42卷 / 02期

关键词：

Fibromyalgia; Diagnosis; Phenotyping; Multimodal assessment; Self-report; Pain; BECK DEPRESSION INVENTORY; PERSONALITY ITEM POOL; PAIN CLINICAL-TRIALS; COGNITIVE DYSFUNCTION; MEDICAL OUTCOMES; POSITIVE AFFECT; QUESTIONNAIRE; VALIDATION; PEOPLE; IMPACT;

D O I：

10.1016/j.rdc.2016.01.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Fibromyalgia (FM) is classified as a chronic pain condition accompanied by symptoms of fatigue, sleep problems, problems with cognition, negative mood, limited functional status, and the presence of other chronic overlapping pain conditions. Comprehensive assessment of all of these components can be challenging. This paper provides an overview of patient-reported approaches that can be taken to assess FM in the contexts of diagnosis, symptom monitoring, phenotyping/characterization, and for purposes of clinical trials.

引用

页码：317 / +

页数：17

共 91 条

[1] A review of the evidence for overlap among unexplained clinical conditions [J].

Aaron, LA ;

Buchwald, D .

ANNALS OF INTERNAL MEDICINE, 2001, 134 (09) :868-881

[2] Biomarkers in fibromyalgia [J].

Ablin, Jacob N. ;

Buskila, Dan ;

Clauw, Daniel J. .

CURRENT PAIN AND HEADACHE REPORTS, 2009, 13 (05) :343-349

[3] PRIMARY FIBROMYALGIA SYNDROME - A VARIANT OF DEPRESSIVE DISORDER [J].

ALFICI, S ;

SIGAL, M ;

LANDAU, M .

PSYCHOTHERAPY AND PSYCHOSOMATICS, 1989, 51 (03) :156-161

[4] Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep) [J].

Allen, Richard P. ;

Kosinski, Mark ;

Hill-Zabala, Christina E. ;

Calloway, Michael O. .

SLEEP MEDICINE, 2009, 10 (05) :531-539

[5]

[Anonymous], 2004, Center for Epidemiologic Studies Depression Scale: Review and Revision (CESD and CESD-R) The use ofpsychological testing for treatment planning and outcomes assessment: Volume 3: Instruments for adults

[6]

[Anonymous], 2011, REL PAIN AM BLUEPR T

[7] Patient perspectives on the impact of fibromyalgia [J].

Arnold, Lesley M. ;

Crofford, Leslie J. ;

Mease, Philip J. ;

Burgess, Somali Misra ;

Palmer, Susan C. ;

Abetz, Linda ;

Martin, Susan A. .

PATIENT EDUCATION AND COUNSELING, 2008, 73 (01) :114-120

[8]

Arnold Lesley M, 2009, Prim Care Companion J Clin Psychiatry, V11, P237, DOI 10.4088/PCC.08m00680

[9] Development of responder definitions for fibromyalgia clinical trials [J].

Arnold, Lesley M. ;

Williams, David A. ;

Hudson, James I. ;

Martin, Susan A. ;

Clauw, Daniel J. ;

Crofford, Leslie J. ;

Wang, Fujun ;

Emir, Birol ;

Lai, Chinglin ;

Zablocki, Rong ;

Mease, Philip J. .

ARTHRITIS AND RHEUMATISM, 2012, 64 (03) :885-894

[10] Assessment of different instruments used as outcome measures in patients with fibromyalgia [J].

Barros Alves, Adriana Martins ;

Natour, Jamil ;

Assis, Marcos Renato ;

Feldman, Daniel .

REVISTA BRASILEIRA DE REUMATOLOGIA, 2012, 52 (04) :496-506

← 1 2 3 4 5 6 7 8 9 10 →